The emerging markets in CE, SE and Eastern Europe include Romania, Poland, Hungary, Turkey, Serbia.

The emerging markets in CE, SE and Eastern Europe include Romania, Poland, Hungary, Turkey, Serbia.
The emerging markets in CE, SE and Eastern Europe include Romania, Poland, Hungary, Turkey, Serbia, Lithuania.

Monday, 17 May 2010

MARKET OPPORTUNITIES IN ROMANIA - 2010 - PHARMA PRODUCTION

The pharma market is the region’s most dynamic, according to regional players. The pharma spending per capita between 2002 and 2006 witnessed a 36% increase in Romania compared to Ukraine’s 28% or the Czech Republic’s 11%.

Around 89% of the pharmaceutical market is supplied by imports. Germany, France and Hungary were the leading suppliers in 2007, accounting for over 40% of the total. Imports grew by 25.8% in 2007, reaching US$1.9 billion.


At present more than 70% of the expenditure on drugs is directed to original, or branded products.

The quality of drug production has risen since the enforcement of GMP on 1st January 2004. However, the number of local drug producers fell from 71 to 31 as a result. Top local producers are: Terapia Ranbaxy, Zentiva, Antibiotice, Actavis, Gedeon Richter Romania SA, LaborMed, Biofarm. Romania became a full member of the European Pharmacopoeia Convention in September 2003, and all medicinal products marketed in the country must be measured against the organisation’s standards.

A number of acquisitions have taken place in the market, including that of Sicomed in September 2005, whereby Zentiva of the Czech Republic obtained a 51% stake in the company, later increasing its share to 74.9%. In March 2006, Actavis, the Icelandic generics manufacturer, acquired Sindan, a Romanian generics company specialising in oncology products, for US$17 million. In the same month, Ranbaxy Laboratories Limited, India’s largest generics manufacturer, acquired Terapia S.A. for US$324 million, purchasing 96.7% of the company’s shares.


Sources:

https://www.espicom.com/Prodcat.nsf/Search/00000365?OpenDocument

http://www.thediplomat.ro/articol.php?id=97


No comments:

Post a Comment

Note: only a member of this blog may post a comment.